DC
MBII

Davenport & Co’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Davenport & Co’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-57,020
Closed -$62K – 1087
2022
Q1 		$62K Sell
57,020
-4,480
-7% -$3.38K ﹤0.01% 1043
2021
Q4 		$44K Sell
61,500
-60,000
-49% -$48.5K ﹤0.01% 1065
2021
Q3 		$109K Buy
121,500
+45,000
+59% +$54.2K ﹤0.01% 1000
2021
Q2 		$127K Buy
76,500
+5,000
+7% +$8.36K ﹤0.01% 918
2021
Q1 		$149K Buy
+71,500
New +$148K ﹤0.01% 767

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Davenport & Co's MBII Position: Q2 2022 in Review

Davenport & Co sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 57,020 shares — an estimated $62K sold.

Davenport & Co first reported a position in MBII in Q1 2021 and held it in 5 quarters. The position peaked at $149K in Q1 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Davenport & Co reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Davenport & Co sold 57,020 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $62K.
  • Davenport & Co first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 5 quarters.
  • Davenport & Co's Marrone Bio Innovations, Inc. position peaked at $149K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Davenport & Co's 13F filing for Q2 2022, filed 18 Jul 2022.